- Home
- PULM vs ZCMD Comparison
PULM vs ZCMD Comparison
Compare PULM & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- ZCMD
- Stock Information
- Founded
- PULM 2003
- ZCMD 2012
- Country
- PULM United States
- ZCMD China
- Employees
- PULM N/A
- ZCMD N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- PULM Health Care
- ZCMD Real Estate
- Exchange
- PULM Nasdaq
- ZCMD Nasdaq
- Market Cap
- PULM 20.5M
- ZCMD 28.5M
- IPO Year
- PULM N/A
- ZCMD 2020
- Fundamental
- Price
- PULM $5.48
- ZCMD $1.02
- Analyst Decision
- PULM
- ZCMD
- Analyst Count
- PULM 0
- ZCMD 0
- Target Price
- PULM N/A
- ZCMD N/A
- AVG Volume (30 Days)
- PULM 11.7K
- ZCMD 44.3K
- Earning Date
- PULM 08-12-2025
- ZCMD 01-01-0001
- Dividend Yield
- PULM N/A
- ZCMD N/A
- EPS Growth
- PULM N/A
- ZCMD N/A
- EPS
- PULM N/A
- ZCMD N/A
- Revenue
- PULM $1,921,000.00
- ZCMD $15,864,773.00
- Revenue This Year
- PULM N/A
- ZCMD N/A
- Revenue Next Year
- PULM $134.88
- ZCMD N/A
- P/E Ratio
- PULM N/A
- ZCMD N/A
- Revenue Growth
- PULM N/A
- ZCMD N/A
- 52 Week Low
- PULM $1.78
- ZCMD $0.95
- 52 Week High
- PULM $10.40
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- PULM 28.72
- ZCMD 39.56
- Support Level
- PULM $5.60
- ZCMD $1.02
- Resistance Level
- PULM $6.15
- ZCMD $1.24
- Average True Range (ATR)
- PULM 0.29
- ZCMD 0.07
- MACD
- PULM -0.08
- ZCMD -0.01
- Stochastic Oscillator
- PULM 4.29
- ZCMD 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.